ESR1 and breast cancer: As a specific subtype of breast cancer, triple-negative breast cancer (TNBC) is characterized by negative estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2), accounting for about 15 ~ 20 % of all breast cancer cases[2].